ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for busy healthcare professionals:
* ATTD Conference Catch-up: Short, AI-generated episodes with key insights from expert presentations & research discussions at the ATTD Conference.
* Curated Series: In-depth, human-led conversations such as our current CGM in Focus series, supported by Dexcom, and previously Long-Acting Insulin Uncovered supported by Eli Lily.
Whether you're a specialist, researcher, or industry leader, hit subscribe.
- Update frequency
- every 3 days
- Average duration
- 26 minutes
- Episodes
- 37
- Years Active
- 2025
CGM research and trends in pregnancy
In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.
She is joined by Dr Denice Feig to discuss the latest research and trends in …
The Future of AI-Driven CGM in Diabetes & Metabolic Health
In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder…
AI-Driven CGM & Personalized Medicine
In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring…
Common Questions Answered; Advancing Long-Acting Insulin in Practice
In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.
They explore a wide range of topi…
Real-World Applications and Success Stories
In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.
They cover:
- Challenges and solutio…
Updates and Emerging Trends in Long-Acting Insulin Therapy
In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.
They cover:
The latest clinica…
Integrating Long-Acting Insulin with Other Therapies
In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.
They discuss combining …
Initiating, Titrating, and Monitoring Long-Acting Insulin
In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.
Their conversation provid…
Patient Selection Criteria for Long-Acting Insulin Therapy
In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.
They explore factors including insulin resistance…
Understanding the Benefits of Long-Acting Insulin
In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.
They explor…
Introduction to Long-Acting Insulin Therapy
In the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insuli…
Introducing ATTD Diabetes Talks: Long-Acting Insulin Uncovered
What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.
Hosted b…
Toward the Cure of Type 1 Diabetes, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed …
Time in Tight Range: Primary Treatment Goal in Diabetes, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate …
Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and ch…
AI-Driven Healthcare: Opportunities and Challenges, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hyperten…
Debate: Adaptive Trials in the Post-Teplizumab Era, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and neces…
Updates on Diabetes Management and Female Health, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of tech…
Type 2 Diabetes: Empowering Patients with Personalized Treatment, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CG…
Decision Support Technologies – Are They Delivering?, ATTD 2025 Conference Catch-Up
In this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabete…